Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma

24 Aug 2022

Abstract excerpt

Background Lung adenocarcinoma (LUAD) is one of the most frequent causes of tumor-related mortality worldwide. Recently, the role of N7-methylguanosine (m7G) in tumors has begun to receive attention, but no investigation on the impact of m7G on LUAD. This study aims to elucidate the significance of m7G on the prognosis and immunotherapy in LUAD. Methods Consensus clustering was employed to determine the molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36091687
DOI: 10.3389/fmed.2022.962972

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinomaPMID 36091687Read ↗

Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung AdenocarcinomaSemantic proximity Read ↗

A Prognostic Risk Score Based on Genes related with m 7 G regulators for the Prognosis and Immunotherapy Response of Lung AdenocarcinomaSemantic proximity Read ↗

A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinomaSemantic proximity Read ↗

A Noval Prognostic Signature of the N7-Methylguanosine (m7G)-Related miRNA in Lung Adenocarcinoma Running title: Prognostic Signature of m7G Related miRNA in Lung AdenocarcinomaSemantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung AdenocarcinomaSemantic proximity Read ↗

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinomaSemantic proximity Read ↗

M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinomaSemantic proximity Read ↗

M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patientsSemantic proximity Read ↗

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)Semantic proximity Read ↗

Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinomaSemantic proximity Read ↗

Identification of prognostic molecular subtypes and model based on CD8+ T cells for lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.